| Date | Time | Venue | Speaker | Country/Region | ||
| Special Session | ||||||
| 25 Aug | 0830-0945 | Hall A | Transplantation in Asia I - Innovative Activities in Organ Transplantation in Asia | |||
| Chairs : | Ghazali AHMAD, Malaysia Maggie MA, Hong Kong, China | |||||
| Topic 1. | Overview of organ transplantation activities in Asia | Jong Cheol JEONG | South Korea | |||
| Topic 2. | The first successful deceased organ transplantation in Bangladesh | Harun Ur RASHID | Bangladesh | |||
| Topic 3. | What has been published in international journals by Asian professionals in transplantation? | Sangho LEE | South Korea | |||
| Topic 4. | How can we publish an article in Transplantation from Asia | Jeremy CHAPMAN | Australia | |||
| Pre-Congress Workshop | ||||||
| 25 Aug | 0830-1010 | Hall C | Transplant Immunology I | |||
| Chairs : | Xian C LI, USA Shiro TAKAHARA, Japan | |||||
| Topic 1. | Tolerance trials: Lessons learned and next steps forward | Sandy FENG | USA | |||
| Topic 2. | mTOR inhibitor in kidney transplantation | Chul-Woo YANG | South Korea | |||
| Topic 3. | Using molecular HLA matching to avoid sensitization | Ruth SAPIR-PICHHADZE | Canada | |||
| Topic 4. | Updated immunosuppression in kidney transplantation | Melissa YEUNG | USA | |||
| Pre-Congress Workshop | ||||||
| 25 Aug | 0830-1010 | Hall B | Transplant Oncology I | |||
| Chairs : | Chi-Leung CHIANG, Hong Kong, China Hiroto EGAWA, Japan | |||||
| Topic 1. | Liver transplantation for colorectal and neuroendocrine liver metastases and hepatoblastoma | Hibi TAIZO | Japan | |||
| Topic 2. | Peri-operative systemic therapy for hepatocellular carcinoma | Lunxiu QIN | Mainland China | |||
| Topic 3. | Updates of the treatment of cholangiocarcinoma - the view from oncologist | Milind JAVLE | USA | |||
| Topic 4. | Liver transplantation for intrahepatic cholangiocarcinoma | Mark GHOBRIAL | USA | |||
| Pre-Congress Workshop | ||||||
| 25 Aug | 0830-1010 | Theatre 2 | Transplant Pathology | |||
| Chairs : | Jimin (Nancy) LIU, Canada Yi WANG, Mainland China | |||||
| Topic 1. | The application of digital pathology and artifical intelligence in transplant pathology | Jimin (Nancy) LIU | Canada | |||
| Topic 2. | Artificial intelligence in anatomical pathology | Zongming Eric CHEN | USA | |||
| Topic 3. | Acute hepatitis and acute liver failure: Pathologic diagnosis and differential diagnosis | Han-Lin WANG | USA | |||
| Topic 4. | Chronic allograft nephropathy | Brian NANKIVELL | Australia | |||
| Special Session | ||||||
| 25 Aug | 0945-1030 | Hall A | Transplantation in Asia II - Update in Organ Transplantation in South Asia | |||
| Chairs : | Ejaz AHMED, Pakistan Kriengsak VAREESANGTHIP, Thailand | |||||
| Topic 1. | Update in organ transplantation in Philippines | Romina DANGUILAN | Philippines | |||
| Topic 2. | Kidney Transplantation in Indonesia | Maruhum Bonar H. MARBUN | Indonesia | |||
| Topic 3. | Update in organ transplantation in Vietnam | An HAI | Vietnam | |||
| Topic 4. | Update in organ transplantation in Myanmar | Khin Maung HTAY | Myanmar | |||
| Pre-Congress Workshop | ||||||
| 25 Aug | 1020-1200 | Hall C | Transplant Immunology II | |||
| Chairs : | Ryoichi IMAMURA, Japan Ken SAKAI, Japan | |||||
| Topic 1. | De novo use of mTOR inhibitors in solid organ transplantation | Bjiorn NASHAN | Mainland China | |||
| Topic 2. | ZERO to ONE and ONE to N | Janette KWOK | Hong Kong, China | |||
| Topic 3. | Update for the therapeutics for acute renal transplant rejection | Ian DITTMER | New Zealand | |||
| Topic 4. | Diagnosis of rejection: DSA and ccDNA | Philip HALLORAN | Canada | |||
| Pre-Congress Workshop | ||||||
| 25 Aug | 1020-1200 | Hall B | Transplant Oncology II | |||
| Chairs : | Albert CY CHAN, Hong Kong, China Francis YAO, USA | |||||
| Topic 1. | Downstaging outcomes for hepatocellular carcinoma before liver transplantation | Neil MEHTA | USA | |||
| Topic 2. | Downstaging - Eastern experience | Yu-Fan CHENG | Taiwan | |||
| Topic 3. | Combinative therapies for cancer recurrence | Xiao XU | Mainland China | |||
| Topic 4. | Updates in Immune therapies for HCC | Thomas YAU | Hong Kong, China | |||
| Topic 5. | Integrated multi-omics profiling to dissect the saptiotemporal evolution of the metastatic hepatocellular carcinoma | Yun-Fan SUN | Mainland China | |||
| Pre-Congress Workshop | ||||||
| 25 Aug | 1020-1200 | Theatre 2 | Infection Diseases and Organ Transplantation | |||
| Chairs : | Wai-Leung CHAK, Hong Kong, China Devinder Singh RANA, India | |||||
| Topic 1. | BK virus revisited | Terence KEE | Singapore | |||
| Topic 2. | SARS-CoV-2 Antibody Kinetics after Two Doses of mRNA Vaccination in Solid Organ Transplant Recipients: Multicenter Study | Kohei UNAGAMI | Japan | |||
| Topic 3. | Management of Mycobacterium Tuberculosis (MTB) in organ transplant patients | Harun Ur RASHID | Bangladesh | |||
| Topic 4. | Vaccination for transplant recipients | Jasper Fuk-Woo CHAN | Hong Kong, China | |||
| Special Session | ||||||
| 25 Aug | 1040-1200 | Hall A | CAST-Vitalink Session - Structure and Function of Organ Procurement Organization in Asia | |||
| Chairs : | Jeremy CHAPMAN, Australia Samuel LEE, South Korea | |||||
| Topic 1. | Basic structure and function of OPO | Jeremy CHAPMAN | Australia | |||
| Topic 2. | Structure and function of OPO in China | Qi-Fa YE | Mainland China | |||
| Topic 3. | Structure and function of OPO in Japan | Yusuke TAKEMURA | Japan | |||
| Topic 4. | Structure and function of OPO in Korea | In Sung MOON | South Korea | |||
| Topic 5. | Structure and function of OPO in Mongolia | Batchuluun PANDAAN | Mongolia | |||
| Special Session | ||||||
| 25 Aug | 1350-1550 | Hall A | AST Ethics Session | |||
| Chairs : | Maung Maung Than KHIN, Myanmar Benita PADILLA, Philippines | |||||
| Topic 1. | How may culture intersect with ethics in deceased donation? | Dominique MARTIN | Australia | |||
| Topic 2. | Is TPM model of deceased donation replicable in other cultures? | Marti MANYALICH | Spain | |||
| Topic 3. | Cultural barriers to implementation of Declaration of Istanbul in organ donation in Asia | Sanjay NAGRAL | India | |||
| Topic 4. | Decisional conflict in living kidney donation - a female perspective | Germaine WONG | Australia | |||
| Pre-Congress Workshop | ||||||
| 25 Aug | 1350-1550 | Hall B | Machine Perfusion | |||
| Chairs : | Xiao-Shun HE, Mainland China Tomoharu YOSHIZUMI, Japan | |||||
| Topic 1. | Normothermic machine perfusion in liver transplantation | Paulo MARTINS | USA | |||
| Topic 2. | Ischemia-free liver transplantation | Zhi-Yong GUO | Mainland China | |||
| Topic 3. | DCD kidney transplantation utilising machine perfusion | Henry PLEASS | Australia | |||
| Topic 4. | Machine perfusion for marginal heart donor - pushing the limit | Oswald Joseph On Jing LEE | Hong Kong, China | |||
| Pre-Congress Workshop | ||||||
| 25 Aug | 1350-1550 | Hall C | Organ Donation & Procurement in Asia | |||
| Chairs : | Feng XUE, Mainland China Chee-Chien YONG, Taiwan | |||||
| Topic 1. | Kidney exchange program in India | Vivek KUTE | India | |||
| Topic 2. | Achieving self-sufficiency in South Korea | Curie AHN | South Korea | |||
| Topic 3. | Opt in vs Opt out: What is the difference? | Shridhar IYER | Singapore | |||
| Topic 4. | Envisioning a sustainable mechanism: Ethical and technical considerations on the organ sharing between Mainland and Hong Kong - Insights from the first historical case | Hai-Bo WANG | Mainland China | |||
| Pre-Congress Workshop | ||||||
| 25 Aug | 1350-1550 | Theatre 2 | Updates in Surgery and Beyond | |||
| Chairs : | Caide LU, Mainland China Chih-Chi WANG, Taiwan | |||||
| Topic 1. | Robot-assisted kidney transplantation | Sung SHIN | South Korea | |||
| Topic 2. | Progress of liver transplantation combined with artificial liver system for treatment of liver failure | Lanjuan LI | Mainland China | |||
| Topic 3. | Minimally invasive donor hepatectomy | Arvinder S. SOIN | India | |||
| Topic 4. | Liver transplantation for hepatocellular carcinoma | Deok-Bog MOON | South Korea | |||
| Date | Time | Venue | Speaker | Country/Region | ||
| Keynote Lecture | ||||||
| 26 Aug | 0830-0930 | Theatre 1 | Keynote Lecture I | |||
| Chairs : | Jia-Hong DONG, Mainland China Ghazali AHMAD, Malaysia | |||||
| Topic 1. | Advances in liver transplantation for hepatocellular carcinoma – A prototype for transplant oncology | John FUNG | USA | |||
| Topic 2. | The art of performing ABO-incompatible liver transplantation | Hiroto EGAWA | Japan | |||
| State-of-the-art Symposium | ||||||
| 26 Aug | 1000-1120 | Theatre 1 | Kidney I - Longevity of Transplant Kidney | |||
| Chairs : | Hideki ISHIDA, Japan Philip Kam-Tao LI, Hong Kong, China | |||||
| Topic 1. | Antibody mediated rejection | Brian NANKIVELL | Australia | |||
| Topic 2. | Immune and non-immune mediated allograft injury ~ the best way of accurate interpretation of kidney allograft ~ | Shiro TAKAHARA | Japan | |||
| Topic 3. | Biomarker in kidney transplantation | Philip HALLORAN | Canada | |||
| Topic 4. | Personalized medicine in kidney transplant | Simon Chi-Yuen CHEUNG | Hong Kong, China | |||
| State-of-the-art Symposium | ||||||
| 26 Aug | 1000-1120 | Hall B | Liver I - Updates in Theranostics in HCC | |||
| Chairs : | Tiffany WONG, Hong Kong, China Hibi TAIZO, Japan | |||||
| Topic 1. | The updates in chonangiocarcinoma | Wojciech POLAK | Netherlands | |||
| Topic 2. | The updated management of NASH and NASH/HCC | Mark MUTHIAH | Singapore | |||
| Topic 3. | Immunotherapies for HCC recipient | Wei-Chen LEE | Taiwan | |||
| Topic 4. | Multidisciplinary therapeutic modalities for HCC | Shu-Sen ZHENG | Mainland China | |||
| State-of-the-art Symposium | ||||||
| 26 Aug | 1000-1120 | Theatre 2 | Heart & Lung I - Heart & Lung | |||
| Chairs : | Chi-Fong WONG, Hong Kong, China Katherine FAN, Hong Kong, China | |||||
| Topic 1. | Lung transplant for COVID patient: China experience | Jing-Yu CHEN | Mainland China | |||
| Topic 2. | Role of bacteriophage in treating resistant infections in lung transplant patients | Gordon L YUNG | USA | |||
| Topic 3. | Novel pathways for increasing donor recovery in heart transplantation | Mandeep MEHRA | USA | |||
| Topic 4. | Transplantation of hearts donated after circulatory-determined death | Steven TSUI | United Kingdom | |||
| State-of-the-art Symposium | ||||||
| 26 Aug | 1000-1120 | Hall A | Pancreas, Xeno, Tissue/Histocompatibility | |||
| Chairs : | Janette KWOK, Hong Kong, China Liang-Xue LAI, Mainland China | |||||
| Topic 1. | The progress and clinical challenging of gene editing for donor pig | Dengke PAN | Mainland China | |||
| Topic 2. | The updates for engraftment of islet/pancreas transplantation | Balamurugan N. APPAKALAI | USA | |||
| Topic 3. | Metabolic outcomes and renal function after simultaneous kidney/pancreas | Ying-Xin FU | Mainland China | |||
| Topic 4. | Xeno-regeneration of humanized hart and kidney in pigs from induced pluripotent stem cells via embryo complementation | Liang-Xue LAI | Mainland China | |||
| State-of-the-art Symposium | ||||||
| 26 Aug | 1130-1250 | Theatre 1 | Kidney II - Kidney Donor Assessment and Selection | |||
| Chairs : | Bo-Ying CHOY, Hong Kong, China Masayoshi OKUMI, Japan | |||||
| Topic 1. | Kidney donor assessment and CKD in kidney donor | Anantharaman VATHSALA | Singapore | |||
| Topic 2. | To take or not to take? Selection of marginal deceased donor | Lai Seong HOOI | Malaysia | |||
| Topic 3. | Equitable deceased donor kidney allocation (including discussion on combined organ transplantation) | Wai LIM | Australia | |||
| Topic 4. | Ethical issues of living kidney donor selection | Kai-Ming CHOW | Hong Kong, China | |||
| State-of-the-art Symposium | ||||||
| 26 Aug | 1130-1250 | Hall B | Liver II - Revisit the Outcomes | |||
| Chairs : | Jae Won JOH, South Korea Qian LU, Mainland China | |||||
| Topic 1. | Liver transplantation using “otherwise-discarded graft” | Jian ZHOU | Mainland China | |||
| Topic 2. | Laparoscopic hepatectomy and robot-assisted liver graft implantation in living donor liver transplantation | Kwang-Woong LEE | South Korea | |||
| Topic 3. | Outflow reconstruction | Xiang-Cheng LI | Mainland China | |||
| State-of-the-art Symposium | ||||||
| 26 Aug | 1130-1250 | Theatre 2 | Heart & Lung II - Heart | |||
| Chairs : | Michael WONG, Hong Kong, China Peter MACDONALD, Australia | |||||
| Topic 1. | Heart Transplantation for congenital heart diseases | Cally HO | Hong Kong, China | |||
| Topic 2. | LVAD utilization in era of organ shortage- are we building the right bridge? | Cumaraswamy SIVATHASAN | Singapore | |||
| Topic 3. | Rejection surveillance after cardia translantation | Peter MACDONALD | Australia | |||
| Topic 4. | Potential role of artificial intelligence in the field of heart transplantation | Kyung Hee KIM | South Korea | |||
| Concurrent Session (Oral Presentation) | ||||||
| 26 Aug | 1420-1600 | Hall B | Liver | |||
| Chairs : | Itsuko Chih-Yi CHEN, Taiwan Zhen-Hua HU, Mainland China | |||||
| OPD-02 | Improved survival after selective portal flow modulation in living donor liver transplantation | Simone Lok Yiu CHAN | Hong Kong, China | |||
| OPD-03 | Impact of portal vein thrombosis on perioperative and long-term outcomes in adult LDLT: A 20-year experience in a high-volume center | Leona Bettina DUNGCA | Taiwan | |||
| OPD-04 | Incidence and risk factors associated with chronic kidney disease after liver transplantation: A review of 20-year experience at a single center | Jirasawet SAWETWANICHAKUL | Thailand | |||
| OPD-05 | Adult living liver donor evaluation outcomes: changes over 2 decades | Allie Ho Kiu POON | Hong Kong, China | |||
| OPD-06 | Graft injury impairs natural killer cell-mediated tumor surveillance after liver transplantation through TLR4/HLA-E/NKG2A axis | Xinxiang YANG | Hong Kong, China | |||
| OPD-07 | Natural killer cells promote granzyme B-dependent hepatic ischemia-reperfusion injury | Zhoucheng WANG | Mainland China | |||
| OPD-09 | Outcomes and risk of relapse after liver transplant for alcoholic liver disease | Chloe Huen-Wai CHOY | Hong Kong, China | |||
| OPD-10 | Outcome of right posterior sector graft in living donor liver transplantation- largest case series | Mukesh KUMAR | India | |||
| OPD-11 | The association of intraoperative hypotension during orthotopic liver transplantation and post-transplant outcomes | Parichat TOVIKKAI | Thailand | |||
| Concurrent Session (Oral Presentation) | ||||||
| 26 Aug | 1420-1600 | Theatre 1 | Kidney | |||
| Chairs : | Lai Seong HOOI, Malaysia Desmond Yat-Hin YAP, Hong Kong, China | |||||
| OPA-01 | Antibody acquisition after second and third doses of SARS-CoV-2 vaccination in Japanese kidney transplant patients: A prospective longitudinal study | Hidetaka DEGUCHI | Japan | |||
| OPA-02 | Outcome of kidney transplantation with extended-criteria deceased-donor kidneys | Maggie K. M. MA | Hong Kong, China | |||
| OPA-03 | Largest report on management protocols and clinical outcomes of living donor abo incompatible kidney transplantation: A multicenter, retrospective, cohort study from India | Meshram HARI SHANKAR | India | |||
| OPA-04 | Precision diagnosis of primary kidney disease in pediatric kidney transplant recipients using genetic sequencing and its clinical value | Jianyi LI | Mainland China | |||
| OPA-05 | The first multicenter clinical trial of machine perfusion preservation for marginal kidney graft in Japan | Naoto MATSUNO | Japan | |||
| OPA-06 | Effect of reconstruction type of dual arteries on long-term outcome in living donor kidney transplantation | Won-Bae CHANG | South Korea | |||
| OPA-07 | The outcomes of adenovirus infection in kidney transplant recipients | Hay Me ME | USA | |||
| OPA-09 | A multicenter retrospective cohort study on management protocols and clinical outcomes after ABO incompatible kidney transplantation in India | VIVEK KUTE | India | |||
| OPA-10 | Prediction of early kidney transplant graft outcome: Insulin resistance index | Tsu-Chen LIN | Taiwan | |||
| OPA-11 | Impact of gender disparity on living donor kidney transplantation – Experience from Singapore general hospital | Chelsi Nicole LEAH | Singapore | |||
| Concurrent Session (Oral Presentation) | ||||||
| 26 Aug | 1420-1600 | Theatre 2 | Basic Science | |||
| Chairs : | Kai WANG, Mainland China Jiang LIU, Hong Kong, China | |||||
| OPC-01 | Decipher the PGC1α-mediated mitochondrial reprogramming in dysregulated immunometabolism during steatotic liver graft injury | Jiang LIU | Hong Kong, China | |||
| OPC-02 | Blocking CD47 promotes anti-tumor immunity through CD103+ Dendritic Cell-NK Cell Axis in hepatocellular carcinoma | shuai WANG | Mainland China | |||
| OPC-03 | Posttransplant carbon monoxide inhalation does not prolong lung transplant acceptance in CLAWN miniature swine | Kazuhiro TAKEUCHI | Japan | |||
| OPC-04 | Alternatively activated (M2) macrophages promoted tumor recurrence via up-regulating complement C3a signaling after liver transplantation | Wai Ho Oscar YEUNG | Mainland China | |||
| OPC-06 | Insulin induced gene 2 protects against hepatic ischemia reperfusion injury via metabolic remodeling | Yichao WU | Mainland China | |||
| OPC-07 | Engineering GPC3-targeting chimeric antigen receptor macrophages (CAR-M) to treat hepatocellular carcinoma | Sheng PAN | Mainland China | |||
| OPC-08 | PAK1 facilitates liver regeneration through alleviating lipid peroxidation | Xun QIU | Mainland China | |||
| OPC-09 | CircRNA 3254 knockdown alleviates the apoptosis of grafted islets via sponging miR-326 | Jingwen WANG | Mainland China | |||
| Concurrent Session (Oral Presentation) | ||||||
| 26 Aug | 1420-1600 | Hall A | Transplant Immunology | |||
| Chairs : | Kuang-Tzu HUANG, Taiwan Hui LIU, Mainland China | |||||
| OPB-01 | HMGB1-mediated CIITA super enhancer is critical to DC1 trained immunity in chronic rejection | Lingjuan SUN | Mainland China | |||
| OPB-02 | Activation of NLRP3 inflammasome by arachidonic acid via FATP2 in MDSCs promotes tumor recurrence after liver transplantation using steatotic graft | Hui LIU | Mainland China | |||
| OPB-03 | Clemastine fumarate potently suppresses mouse heart transplantation acute rejection | Yongcheng WEI | Mainland China | |||
| OPB-04 | Engineered IL-2 plus calcineurin inhibitor synergistically expands regulatory t cells transduced with engineered IL-2 receptor and facilitates establishment of transplantation tolerance | Toshihito HIRAI | Japan | |||
| OPB-05 | FGF21 modulates immunometabolism reprogramming through ALOX15/15-HETE axis to alleviate acute graft injury after liver transplantation | Di LU | Mainland China | |||
| OPB-06 | Bone transplantation: Does a new decellularization protocol improve the in vivo outcome for massive bone allograft? Preliminary results | Robin EVRARD | Belgium | |||
| OPB-07 | VISTA alleviates post-transplantation acute rejection by upregulating IL10 and modulating macrophage polarization | Lifei LIANG | Mainland China | |||
| OPB-09 | Preconditioning using rituximab in kidney transplantation reduces incidence of acute T-cell mediated rejection and prevents development of anti-HLA antibody | Takayuki HIROSE | Japan | |||
| OPB-10 | Midkine promote renal fibrosis by inhibiting CD31+ACTA2+ECs apoptosis during EndMT | Cuidi XU | Mainland China | |||
| OPB-11 | Computational analysis of multiplex immunofluorescence imaging identifies endothelial cell-macrophage interaction as a potential novel spatial biomarker in antibody mediated kidney rejection | Toshihito HIRAI | Japan | |||
| State-of-the-art Symposium | ||||||
| 26 Aug | 1620-1800 | Theatre 2 | Heart & Lung III - Lung | |||
| Chairs : | Michael HSIN, Hong Kong, China See-Wan YAN, Hong Kong, China | |||||
| Topic 1. | Living donor lung transplantation | Masaaki SATO | Japan | |||
| Topic 2. | Extracorporeal life support as a bridge to lung transplantation | Konrad HOETZENECKER | Austria | |||
| Topic 3. | Normothermic ex vivo lung perfusion - donor lung assessment and repair | Marcelo CYPEL | Canada | |||
| Topic 4. | The journey to lung transplantation in the Philippines | Jose Luis J. DANGUILAN | Philippines | |||
| Special Session | ||||||
| 26 Aug | 1620-1800 | Hall A | TID-CAST Symposium | |||
| Chairs : | Ivan HUNG, Hong Kong, China Ban Hock TAN, Singapore | |||||
| Topic 1. | CMV – an update | Ban Hock TAN | Singapore | |||
| Topic 2. | MDROs pre- and post-transplant | Kyungmin HUH | South Korea | |||
| Topic 3. | Tuberculosis in transplantation | Neha Rastogi PANDA | India | |||
| Topic 4. | Tropical viruses in transplantation | Siriorn WATCHARANAN | Thailand | |||
| State-of-the-art Symposium | ||||||
| 26 Aug | 1620-1800 | Theatre 1 | Kidney III - Challenges in Kidney Transplantation | |||
| Chairs : | Sangho LEE, South Korea William LEE, Hong Kong, China | |||||
| Topic 1. | Management of highly sensitized kidney transplant candidates | Melissa YEUNG | USA | |||
| Topic 2. | Kidney transplantation in elderly | Germaine WONG | Australia | |||
| Topic 3. | Management of the failing kidney transplant | Hsu-Han WANG | Taiwan | |||
| Topic 4. | Hepatitis B infection in transplant recipients | Desmond Yat-Hin YAP | Hong Kong, China | |||
| State-of-the-art Symposium | ||||||
| 26 Aug | 1620-1800 | Hall B | Liver III | |||
| Chairs : | Guo-yue LV, Mainland China Albert CY CHAN, Hong Kong, China | |||||
| Topic 1. | Prevention of recurrenc in viral hepatities B and C after liver transplantation | James FUNG | Hong Kong, China | |||
| Topic 2. | Downstaging HCC for LT | Albert CY CHAN | Hong Kong, China | |||
| Topic 3. | Predictors of outcomes following liver transplantation | John R. LAKE | USA | |||
| Topic 4. | Downstaging of hepatocellular carcinoma for liver transplantation | Francis YAO | USA | |||
| Topic 5. | Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management | Patrizia BURRA | Italy | |||
| Date | Time | Venue | Speaker | Country/Region | ||
| Keynote Lecture | ||||||
| 27 Aug | 0830-0930 | Theatre 1 | Keynote Lecture II | |||
| Chairs : | Curie AHN, South Korea John R. LAKE, USA | |||||
| Topic 1. | Growing organs in vivo: iPS cell-derived, xeno-created organs for transplantation | Hiromitsu NAKAUCHI | Japan | |||
| Topic 2. | Disparity of transplantation in Asia | Maggie MA | Hong Kong, China | |||
| Special Session | ||||||
| 27 Aug | 1000-1120 | Hall A | CAST-Eye Bank Special Session I: Variations in Eye Banking in Different Localities - Successes and Challenges | |||
| Chairs : | Vanissa CHOW, Hong Kong, China Bernardita NAVARRO, Phillipines | |||||
| Topic 1. | Eye Banking in Hong Kong, China | Vanissa CHOW | Hong Kong, China | |||
| Topic 2. | Eye Banking in Mainland China | Wei-Yun SHI | Mainland China | |||
| Topic 3. | Unfolding the new chapter of the Philippine eye bank | Bernardita NAVARRO | Phillipines | |||
| Topic 4. | Eye Banking in Japan | Koji KITAZAWA | Japan | |||
| Topic 5. | Future-Proofing the Eye Bank | Howard Cajucom-Uy YU | Singapore | |||
| Topic 6. | A 5-year review of Keratoplasty in China | Suxia LI | Mainland China | |||
| State-of-the-art Symposium | ||||||
| 27 Aug | 1000-1120 | Theatre 1 | Kidney IV - Overcoming Immunological Barrier | |||
| Chairs : | Jongwon HA, South Korea Maggie MA, Hong Kong, China | |||||
| Topic 1. | Transplantation across immunological barrier | Kazunari TANABE | Japan | |||
| Topic 2. | Paired kidney donation | Wai LIM | Australia | |||
| Topic 3. | DCreg cell therapy to induce transplant tolerance: from bench to bedside | He-Long DAI | Mainland China | |||
| Topic 4. | The role of donor kidney resident macrophages in kidney allograft injury | Xun-Rong LUO | USA | |||
| State-of-the-art Symposium | ||||||
| 27 Aug | 1000-1120 | Hall B | Liver IV | |||
| Chairs : | See-Ching CHAN, Hong Kong, China Cheng-Maw HO, Taiwan | |||||
| Topic 1. | Bridging or downstaging locally advanced HCC to LDLT | Chao-Long CHEN | Taiwan | |||
| Topic 2. | Defatting strategies in the current era of liver steatosis | Nazia SELZNER | Canada | |||
| Topic 3. | Liver transplantation in patients with portal vein thrombosis: A strategic road map throughout management | Shintaro YAGI | Japan | |||
| Topic 4. | Dynamic immune recovery process after liver transplantation revealed by single-cell multi-omics analysis | Zhi-Hai PENG | Mainland China | |||
| State-of-the-art Symposium | ||||||
| 27 Aug | 1000-1120 | Theatre 2 | Advances in Basic & Translational Research I | |||
| Chairs : | Xiao-Kang LI, Japan Zhe YANG, Mainland China | |||||
| Topic 1. | Liver-Gut axis in immune regulation | Jun YU | Hong Kong, China | |||
| Topic 2. | The updates of innate immune regulations and liver ischemia-reperfusion injury | Yuan ZHAI | USA | |||
| Topic 3. | The mechanisms of regulating the progression of non-alcoholic steatohepatitis | Ling LU | Mainland China | |||
| Topic 4. | The role of NK cells in immune response during liver transplantation | Hideki OHDAN | Japan | |||
| Special Session | ||||||
| 27 Aug | 1130-1250 | Hall A | CAST-Eye Bank Special Session II: Advances in Corneal Transplantation in the Past Decade | |||
| Chairs : | Wei-Yun SHI, Mainland China Alvin YOUNG, Hong Kong, China | |||||
| Topic 1. | Donor corneal endothelial cell maturity influences graft survival | Koji KITAZAWA | Japan | |||
| Topic 2. | Lamellar keratoplasty | Julia CHAN | Hong Kong, China | |||
| Topic 3. | Cell-based therapies for the corneal endothelium | Hon Shing ONG | Singapore | |||
| Topic 4. | Stem cell transplant | Aziz KAM | Hong Kong, China | |||
| Topic 5. | Synthetic corneal replacement | Vanissa CHOW | Hong Kong, China | |||
| Topic 6. | Protectively decellularized porcine cornea versus human donor cornea for lamellar transplantation | Wei-Yun SHI | Mainland China | |||
| State-of-the-art Symposium | ||||||
| 27 Aug | 1130-1250 | Theatre 1 | Kidney V - Non-immune Complication of Kidney Transplant | |||
| Chairs : | Alison Lap-Tak MA, Hong Kong, China Khin Thida THWIN, Myanmar | |||||
| Topic 1. | Diabetes mellitus after kidney transplantation | Sydney Chi-Wai TANG | Hong Kong, China | |||
| Topic 2. | Post-transplant lymphoproliferative disorders after kidney transplantation | Ryoichi IMAMURA | Japan | |||
| Topic 3. | Optimizing cardiovascular risk factor in kidney transplant recipient | Pearl PAI | Mainland China | |||
| Topic 4. | Obesity and kidney transplantation | Michele M A YUEN | Hong Kong, China | |||
| State-of-the-art Symposium | ||||||
| 27 Aug | 1130-1250 | Hall B | Liver V | |||
| Chairs : | Tan-To CHEUNG, Hong Kong, China James FUNG, Hong Kong, China | |||||
| Topic 1. | Liver transplant for non -alcoholic steatohepatitis | Geoffrey MCCAUGHAN | Australia | |||
| Topic 2. | Updates of biliary complication after liver transplantation | Siu Ho Kenneth CHOK | Hong Kong, China | |||
| Topic 3. | Living donor liver transplantation for alcohol-related liver disease | Prashant BHANGUI | India | |||
| Topic 4. | Auxiliary liver transplantation with small graft for severe portal hypertension related to cirrhotic liver diseases | Zhi-Jun ZHU | Mainland China | |||
| State-of-the-art Symposium | ||||||
| 27 Aug | 1130-1250 | Theatre 2 | Advances in Basic & Translational Research II | |||
| Chairs : | Xin-Rong YANG, Mainland China Kuang-Tzu HUANG, Taiwan | |||||
| Topic 1. | The roles of graft-resident donor macrophages on regulating transplant outcome | Xian C LI | USA | |||
| Topic 2. | Molecular mechanisms of estradiol attenuating renal ischemia-reperfusion injury | Yan-Feng WANG | Mainland China | |||
| Topic 3. | Individual management of the immunosuppressants in liver transplantation recipients by using a novel immune score system | Xian-Liang LI | Mainland China | |||
| Topic 4. | The roles of dendrtic cells on tumor suppressive environment | Li PANG | Mainland China | |||
| Special Session | ||||||
| 27 Aug | 1420-1600 | Hall A | CAST-WTGF Special Session - Sports and exercise after organ transplantation | |||
| Chair : | Liz SCHICK, Switzerland | |||||
| Topic 1. | Sport: An invaluable tool for patient engagement | Paul HARDEN | United Kingdom | |||
| Topic 2. | Refit for life | Liz SCHICK | Switzerland | |||
| Topic 3. | How to encourage transplant recipients to start exercising | Ka-Foon CHAU | Hong Kong, China | |||
| Topic 4. | Post transplant rehabilitation and sports | Elton Chun-Ting NG | Hong Kong, China | |||
| Topic 5. | Using sport to regain health - My transplant sports journey | Martin Yim-Wah WONG | Hong Kong, China | |||
| Concurrent Session (Oral Presentation) | ||||||
| 27 Aug | 1420-1600 | Theatre 1 | Transplant Oncology, Pathology and Imaging | |||
| Chairs : | Wong-hoi SHE, Hong Kong, China Xin-Xiang YANG, Hong Kong, China | |||||
| OPE-01 | How far could Hangzhuo criteria achieve: Combination of the PIVKA-II with Hangzhou criteria to predict HCC recurrence after liver transplantation. | Libin DONG | Mainland China | |||
| OPE-02 | Rapamycin-loaded nanoparticles elicit local liver immunosuppressive and remote anti-tumor efficacy | Yiyang SUN | Mainland China | |||
| OPE-03 | Primary central nervous system post-transplant lymphoproliferative disease in Chinese kidney transplant recipients | Chi Yuen Simon CHEUNG | Hong Kong, China | |||
| OPE-05 | Metabolic reprogramming of polyunsaturated fatty acids in fatty graft promotes post-transplant HCC recurrence via FADS1 overexpression | Tao DING | Hong Kong, China | |||
| OPE-06 | Influence of TP53 mutation status on benefit of sirolimus in liver transplant recipient of hepatocellular carcinoma | Jiongjie YU | Mainland China | |||
| OPE-07 | Short-term outcome of kidney allografts with biopsy-proven pre-existing diabetic nephropathy: the value of Remuzzi score and RPS grade. | Jiali WANG | Mainland China | |||
| OPE-08 | Drug-eluting embolizer transarterial chemoembolization for hepatocellular carcinoma: Efficacy of different particle sizes in downstaging or bridging in living donor liver transplantation | Kuan Siong SIM | Taiwan | |||
| OPE-09 | Validation of original and modified pathological scoring systems for prognostic value in donor kidney core biopsy. | Jinghong TAN | Mainland China | |||
| OPE-10 | Diagnostic value and assessment of treatment efficacy of 18F-FDG PET/CT in pediatric patients with posttransplant lymphoproliferative disorder after liver transplantation | Jing-Yi LIU | Mainland China | |||
| Concurrent Session (Oral Presentation) | ||||||
| 27 Aug | 1420-1600 | Hall B | Outcomes | |||
| Chairs : | Jeff WC DAI, Hong Kong, China Ai-Hua YAO, Mainland China | |||||
| OPF-01 | Long-term Outcomes of Liver Transplantation for Methylmalonic Acidemia: New Insights into Health-related Quality of Life | Yi-Zhou JIANG | Mainland China | |||
| OPF-02 | Epidemiology and risk factors of early bacterial infections after pediatric living donor liver transplantation | Itsuko Chih-Yi CHEN | Taiwan | |||
| OPF-03 | Predictive model of EBV-related PTLD after liver transplantation in children | Jing-Yi LIU | Mainland China | |||
| OPF-04 | Relationship between arterioplasty and renal prognosis in renal transplantation | Shota INOUE | Japan | |||
| OPF-05 | SARS-CoV-2 antibody kinetics after vaccination in kidney transplant recipients: Multicenter study | Rikako OKI | Japan | |||
| OPF-06 | Renal outcomes of recipient and donor according to predonation GFR | John Neal BASTONA | Philippines | |||
| OPF-07 | SGLT2 inhibition in kidney transplant recipients: a 6-year experience | Maggie K. M. MA | Hong Kong, China | |||
| OPF-08 | Frailty and lean tissue wasting predict transplant waitlist candidacy and delisting | Chun Kau Gordon CHAN | Hong Kong, China | |||
| OPF-09 | The impact of COVID-19 on heart transplant recipients in an Asian city | Ka Lam WONG | Hong Kong, China | |||
| OPF-10 | Comparison of outcomes of DSAEK(Descemet’s Stripping Automated Endothelial Keratoplasty) and DMEK(Descemet's Membrane Endothelial Keratoplasty) by novice surgeons | Gillian SIU | Hong Kong, China | |||
| OPF-11 | Tectonic deep anterior lamellar keratoplasty to treat corneal perforation and descemetocele from microbial keratitis | Hong NGUYEN | Vietnam | |||
| Concurrent Session (Oral Presentation) | ||||||
| 27 Aug | 1420-1600 | Theatre 2 | Xenotransplantation, Donation and Ethics | |||
| Chairs : | Bjiorn NASHAN, Mainland China Dengke PAN, Mainland China | |||||
| OPG-02 | Screening PBMCs for porcine CMV rather than serum is predictive for transplant outcomes after pig to cynomolgus xenogeneic kidney transplantation | Eun Sung JEONG | South Korea | |||
| OPG-03 | Could a decellularization protocol be validated without talking about HLA? | Julie MANON | Belgium | |||
| OPG-04 | Impact of COVID-19 on corneal donation and transplantation in Hong Kong | Wing Yan Rachel TSUI | Hong Kong, China | |||
| OPG-05 | Improving donation through education for health professionals: Belt & Road Organ Donation Capacity Improvement Cooperation Training Project (BROAOD) | Jie ZHAO | Mainland China | |||
| OPG-07 | To achieve effective communication with organ donor family: Key points from the Chinese expert consensus working group | Wenshi JIANG | Mainland China | |||
| OPG-09 | The current situation deceased donor organ transplantation development in Mongolia | Batchuluun PANDAAN | Mongolia | |||
| State-of-the-art Symposium | ||||||
| 27 Aug | 1620-1800 | Theatre 1 | Anaesthesia & Peri-operative Management | |||
| Chairs : | Anil SINGH, India Li-Ying SUN, Mainland China | |||||
| Topic 1. | Perioperative management - over view | Pooja BHANGUI | India | |||
| Topic 2. | Perioperative management of liver transplantation for severe hepatopulmonary syndrome | Li-Ying SUN | Mainland China | |||
| Topic 3. | Perioperative management of LT in ALF and ACLF | Ashish MALIK | India | |||
| Topic 4. | Management of sepsis in transplant recipients | Simon SIN | Hong Kong, China | |||
| State-of-the-art Symposium | ||||||
| 27 Aug | 1620-1800 | Hall B | Paediatrics | |||
| Chairs : | Chao-Long CHEN, Taiwan Alison Lap-Tak MA, Hong Kong, China | |||||
| Topic 1. | Marginal parental donors for pediatric living donor liver transplantation | Seisuke SAKAMOTO | Japan | |||
| Topic 2. | The updates of liver transplantation for hepatoblastoma | Feng XUE | Mainland China | |||
| Topic 3. | The CMV infection in paediatric liver transplantation | Yan-Jun SHI | Mainland China | |||
| Topic 4. | Novel experimental model of AMR | Pankaj CHANDAK | United Kingdom | |||
| Date | Time | Venue | Speaker | Country/Region | ||
| Keynote Lecture | ||||||
| 28 Aug | 0815-0915 | Theatre 1 | Keynote Lecture III | |||
| Chairs : | Albert CY CHAN, Hong Kong, China Hai-Bo WANG, Mainland China | |||||
| Topic 1. | Transplant economics | Alvin ROTH | USA | |||
| Topic 2. | Organ transplantation reform in China: The synergy of Chinese cultural traditions and WHO guiding principle | Jie-Fu HUANG | Mainland China | |||
| State-of-the-art Symposium | ||||||
| 28 Aug | 1000-1120 | Hall B | New Technologies - Bioengineering I | |||
| Chairs : | Eiji KOBAYASHI, Japan Li PANG, Mainland China | |||||
| Topic 1. | The pig as an in vivo bioreactor for human organs | Eiji KOBAYASHI | Japan | |||
| Topic 2. | Smart materials for liver transplant oncology | Nasha QIU | Mainland China | |||
| Topic 3. | Bioartificial lung grafts | Harald OTT | USA | |||
| Topic 4. | Micro-robot for tissue repair and cancer therapy | Jiang LIU | Hong Kong, China | |||
| State-of-the-art Symposium | ||||||
| 28 Aug | 1000-1120 | Theatre 1 | New Technologies - Digital Imaging | |||
| Chairs : | Kyongtae Ty BAE, Hong Kong, China Keith Wan-Hang CHIU, Hong Kong, China | |||||
| Topic 1. | AI and digital imaging | Kyongtae Ty BAE | Hong Kong, China | |||
| Topic 2. | Digital and intelligent liver imaging | Xiao-Long QI | Mainland China | |||
| Topic 3. | 3D reconstruction software with augmented and mixed reality for living donor liver transplantation | Deniz BALCI | Turkey | |||
| Topic 4. | Radiomics in kidney transplantation: A scoping review of current applications, limitations, and future directions | Valerie Huei Li GAN | Singapore | |||
| Special Session | ||||||
| 28 Aug | 1000-1250 | Hall A | Updates in Asian Registry ASTREG / Living Donor Registry | |||
| Chairs : | Vasanthi RAMESH, India Kenji YUZAWA, Japan | |||||
| Topic 1. | Spectrum of living donation in Asia – Perspectives from the ASTREG data | Jong Cheol JEONG | South Korea | |||
| Topic 2. | Improving care of living donors through registries – experience from the United States | Naoka MURAKAMI | USA | |||
| Topic 3. | Caring for living donors in Asia – current status and challenges of donor follow-up and management in Japan | Yuki NAKAGAWA | Japan | |||
| Topic 4. | The living kidney donor registry in India | Ashish SHARMA | India | |||
| Topic 5. | The living donor registry in Philippines | Mel-Hatra ARAKAMA | Philippines | |||
| Topic 6. | The living donor registry in Hong Kong | John YH CHAN | Hong Kong, China | |||
| Topic 7. | The living donor registry in Kuwait | Hussain AL-MAHMEED | Kuwait | |||
| Topic 8. | Panel discussion | Terence KEE | Singapore | |||
| State-of-the-art Symposium | ||||||
| 28 Aug | 1130-1250 | Hall B | New Technologies - Bioengineering II | |||
| Chairs : | Hiroshi YAGI, Japan Oscar YEUNG, Hong Kong, China | |||||
| Topic 1. | Establishing respiratory organoids for modeling viral infections | Jane ZHOU | Hong Kong, China | |||
| Topic 2. | Bioengineered human liver for transplantation | Hiroshi YAGI | Japan | |||
| Topic 3. | Organoids for patho-mechanistic study of newborn hepatobiliary diseases | Vincent CH LUI | Hong Kong, China | |||
| Topic 4. | Hepatic organoids for cancer risk prediction | Nathalie WONG | Hong Kong, China | |||
| State-of-the-art Symposium | ||||||
| 28 Aug | 1130-1250 | Theatre 1 | New Technologies - Biomarkers and Prediction Models | |||
| Chairs : | Chao LIU, Mainland China Zhongyang SHEN, Mainland China | |||||
| Topic 1. | Prediction models for hepatocellular cancer recurrence after liver transplantation | Jan LERUT | Belgium | |||
| Topic 2. | The role of CTC on predction of cancer reucrrence after transplantation | Xin-Rong YANG | Mainland China | |||
| Topic 3. | Noninvasive biomarkers in NAFLD and NASH - current progress and future promise | Vincent WONG | Hong Kong, China | |||
| Topic 4. | Post-transplant inflammatory cytokine signature for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma | Kevin Tak-Pan NG | Hong Kong, China | |||
| Special Session | ||||||
| 28 Aug | 1430-1600 | Hall A | Asian Women in Transplantation - Gender Issues in Transplantation-Biologic Perspectives | |||
| Chairs : | Itsuko Chih-Yi CHEN, Taiwan Yeong Hoon KIM, South Korea | |||||
| Topic 1. | Paradoxical effects of pregnancy on transplantation | Anita S CHONG | USA | |||
| Topic 2. | Genes, hormones, and alloimmunity | Yuka TANAKA | Japan | |||
| Topic 3. | Sex hormones and their influenced on the kidney | Yunmi KIM | South Korea | |||
| Topic 4. | Gender disparities in liver transplantation | Qin-Fen XIE | Mainland China | |||
| State-of-the-art Symposium | ||||||
| 28 Aug | 1430-1600 | Theatre 1 | New Technologies - AI and Single Cell Sequencing | |||
| Chairs : | Sonya MACPARLAND, Canada Kevin Tak-Pan NG, Hong Kong, China | |||||
| Topic 1. | Interpretable machine learning improves prediction of early allograft failure after liver transplantation | Jian-Dong ZHOU | United Kingdom | |||
| Topic 2. | Application of machine learning in liver transplantation | Mamatha BHAT | Canada | |||
| Topic 3. | Unraveling the complexity of liver disease one cell at a time | Sonya MACPARLAND | Canada | |||
| Topic 4. | Machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis | Grace Lai-Hung WONG | Hong Kong, China | |||
| State-of-the-art Symposium | ||||||
| 28 Aug | 1430-1600 | Hall B | New Technologies - Bionic Model and Tissue Repair | |||
| Chairs : | Zhen-Hua HU, Mainland China Wai Ho Oscar YEUNG, Mainland China | |||||
| Topic 1. | 3D/4D bioprinting | Jian LU | Hong Kong, China | |||
| Topic 2. | Patient-specific 3D printing: A novel technique for complex pediatric renal transplantation | Pankaj CHANDAK | United Kingdom | |||
| Topic 3. | Three-dimensional bioprinted hepatorganoids | Yi-Lei MAO | Mainland China | |||
| Topic 4. | Expanded potential stem cell for xenotransplantation | Pengtao LIU | Hong Kong, China | |||
| Keynote Lecture | |
|---|---|
| Session: | Keynote Lecture I Date: 26 Aug | Time:0830-0930 | Venue: Theatre 1 |
| Chairs : | Jia-Hong DONG, Mainland China Ghazali AHMAD, Malaysia |
| Topic 1. | Advances in liver transplantation for hepatocellular carcinoma – A prototype for transplant oncology John FUNG, USA |
| Topic 2. | The art of performing ABO-incompatible liver transplantation Hiroto EGAWA, Japan |
| Session: | Keynote Lecture II Date: 27 Aug | Time:0830-0930 | Venue: Theatre 1 |
| Chairs : | Curie AHN, South Korea John R. LAKE, USA |
| Topic 1. | Growing organs in vivo: iPS cell-derived, xeno-created organs for transplantation Hiromitsu NAKAUCHI, Japan |
| Topic 2. | Disparity of transplantation in Asia Maggie MA, Hong Kong, China |
| Session: | Keynote Lecture III Date: 28 Aug | Time:0815-0915 | Venue: Theatre 1 |
| Chairs : | Albert CY CHAN, Hong Kong, China Hai-Bo WANG, Mainland China |
| Topic 1. | Transplant economics Alvin ROTH, USA |
| Topic 2. | Organ transplantation reform in China: The synergy of Chinese cultural traditions and WHO guiding principle Jie-Fu HUANG, Mainland China |
| Concurrent Session (Oral Presentation) | |
|---|---|
| Session: | Liver Date: 26 Aug | Time:1420-1600 | Venue: Hall B |
| Chairs : | Itsuko Chih-Yi CHEN, Taiwan Zhen-Hua HU, Mainland China |
| OPD-02 | Improved survival after selective portal flow modulation in living donor liver transplantation Simone Lok Yiu CHAN, Hong Kong, China |
| OPD-03 | Impact of portal vein thrombosis on perioperative and long-term outcomes in adult LDLT: A 20-year experience in a high-volume center Leona Bettina DUNGCA, Taiwan |
| OPD-04 | Incidence and risk factors associated with chronic kidney disease after liver transplantation: A review of 20-year experience at a single center Jirasawet SAWETWANICHAKUL, Thailand |
| OPD-05 | Adult living liver donor evaluation outcomes: changes over 2 decades Allie Ho Kiu POON, Hong Kong, China |
| OPD-06 | Graft injury impairs natural killer cell-mediated tumor surveillance after liver transplantation through TLR4/HLA-E/NKG2A axis Xinxiang YANG, Hong Kong, China |
| OPD-07 | Natural killer cells promote granzyme B-dependent hepatic ischemia-reperfusion injury Zhoucheng WANG, Mainland China |
| OPD-09 | Outcomes and risk of relapse after liver transplant for alcoholic liver disease Chloe Huen-Wai CHOY, Hong Kong, China |
| OPD-10 | Outcome of right posterior sector graft in living donor liver transplantation- largest case series Mukesh KUMAR, India |
| OPD-11 | The association of intraoperative hypotension during orthotopic liver transplantation and post-transplant outcomes Parichat TOVIKKAI, Thailand |
| Session: | Kidney Date: 26 Aug | Time:1420-1600 | Venue: Theatre 1 |
| Chairs : | Lai Seong HOOI, Malaysia Desmond Yat-Hin YAP, Hong Kong, China |
| OPA-01 | Antibody acquisition after second and third doses of SARS-CoV-2 vaccination in Japanese kidney transplant patients: A prospective longitudinal study Hidetaka DEGUCHI, Japan |
| OPA-02 | Outcome of kidney transplantation with extended-criteria deceased-donor kidneys Maggie K. M. MA, Hong Kong, China |
| OPA-03 | Largest report on management protocols and clinical outcomes of living donor abo incompatible kidney transplantation: A multicenter, retrospective, cohort study from India Meshram HARI SHANKAR, India |
| OPA-04 | Precision diagnosis of primary kidney disease in pediatric kidney transplant recipients using genetic sequencing and its clinical value Jianyi LI, Mainland China |
| OPA-05 | The first multicenter clinical trial of machine perfusion preservation for marginal kidney graft in Japan Naoto MATSUNO, Japan |
| OPA-06 | Effect of reconstruction type of dual arteries on long-term outcome in living donor kidney transplantation Won-Bae CHANG, South Korea |
| OPA-07 | The outcomes of adenovirus infection in kidney transplant recipients Hay Me ME, USA |
| OPA-09 | A multicenter retrospective cohort study on management protocols and clinical outcomes after ABO incompatible kidney transplantation in India VIVEK KUTE, India |
| OPA-10 | Prediction of early kidney transplant graft outcome: Insulin resistance index Tsu-Chen LIN, Taiwan |
| OPA-11 | Impact of gender disparity on living donor kidney transplantation – Experience from Singapore general hospital Chelsi Nicole LEAH, Singapore |
| Session: | Basic Science Date: 26 Aug | Time:1420-1600 | Venue: Theatre 2 |
| Chairs : | Kai WANG, Mainland China Jiang LIU, Hong Kong, China |
| OPC-01 | Decipher the PGC1α-mediated mitochondrial reprogramming in dysregulated immunometabolism during steatotic liver graft injury Jiang LIU, Hong Kong, China |
| OPC-02 | Blocking CD47 promotes anti-tumor immunity through CD103+ Dendritic Cell-NK Cell Axis in hepatocellular carcinoma shuai WANG, Mainland China |
| OPC-03 | Posttransplant carbon monoxide inhalation does not prolong lung transplant acceptance in CLAWN miniature swine Kazuhiro TAKEUCHI, Japan |
| OPC-04 | Alternatively activated (M2) macrophages promoted tumor recurrence via up-regulating complement C3a signaling after liver transplantation Wai Ho Oscar YEUNG, Mainland China |
| OPC-06 | Insulin induced gene 2 protects against hepatic ischemia reperfusion injury via metabolic remodeling Yichao WU, Mainland China |
| OPC-07 | Engineering GPC3-targeting chimeric antigen receptor macrophages (CAR-M) to treat hepatocellular carcinoma Sheng PAN, Mainland China |
| OPC-08 | PAK1 facilitates liver regeneration through alleviating lipid peroxidation Xun QIU, Mainland China |
| OPC-09 | CircRNA 3254 knockdown alleviates the apoptosis of grafted islets via sponging miR-326 Jingwen WANG, Mainland China |
| Session: | Transplant Immunology Date: 26 Aug | Time:1420-1600 | Venue: Hall A |
| Chairs : | Kuang-Tzu HUANG, Taiwan Hui LIU, Mainland China |
| OPB-01 | HMGB1-mediated CIITA super enhancer is critical to DC1 trained immunity in chronic rejection Lingjuan SUN, Mainland China |
| OPB-02 | Activation of NLRP3 inflammasome by arachidonic acid via FATP2 in MDSCs promotes tumor recurrence after liver transplantation using steatotic graft Hui LIU, Mainland China |
| OPB-03 | Clemastine fumarate potently suppresses mouse heart transplantation acute rejection Yongcheng WEI, Mainland China |
| OPB-04 | Engineered IL-2 plus calcineurin inhibitor synergistically expands regulatory t cells transduced with engineered IL-2 receptor and facilitates establishment of transplantation tolerance Toshihito HIRAI, Japan |
| OPB-05 | FGF21 modulates immunometabolism reprogramming through ALOX15/15-HETE axis to alleviate acute graft injury after liver transplantation Di LU, Mainland China |
| OPB-06 | Bone transplantation: Does a new decellularization protocol improve the in vivo outcome for massive bone allograft? Preliminary results Robin EVRARD, Belgium |
| OPB-07 | VISTA alleviates post-transplantation acute rejection by upregulating IL10 and modulating macrophage polarization Lifei LIANG, Mainland China |
| OPB-09 | Preconditioning using rituximab in kidney transplantation reduces incidence of acute T-cell mediated rejection and prevents development of anti-HLA antibody Takayuki HIROSE, Japan |
| OPB-10 | Midkine promote renal fibrosis by inhibiting CD31+ACTA2+ECs apoptosis during EndMT Cuidi XU, Mainland China |
| OPB-11 | Computational analysis of multiplex immunofluorescence imaging identifies endothelial cell-macrophage interaction as a potential novel spatial biomarker in antibody mediated kidney rejection Toshihito HIRAI, Japan |
| Session: | Transplant Oncology, Pathology and Imaging Date: 27 Aug | Time:1420-1600 | Venue: Theatre 1 |
| Chairs : | Wong-hoi SHE, Hong Kong, China Xin-Xiang YANG, Hong Kong, China |
| OPE-01 | How far could Hangzhuo criteria achieve: Combination of the PIVKA-II with Hangzhou criteria to predict HCC recurrence after liver transplantation. Libin DONG, Mainland China |
| OPE-02 | Rapamycin-loaded nanoparticles elicit local liver immunosuppressive and remote anti-tumor efficacy Yiyang SUN, Mainland China |
| OPE-03 | Primary central nervous system post-transplant lymphoproliferative disease in Chinese kidney transplant recipients Chi Yuen Simon CHEUNG, Hong Kong, China |
| OPE-05 | Metabolic reprogramming of polyunsaturated fatty acids in fatty graft promotes post-transplant HCC recurrence via FADS1 overexpression Tao DING, Hong Kong, China |
| OPE-06 | Influence of TP53 mutation status on benefit of sirolimus in liver transplant recipient of hepatocellular carcinoma Jiongjie YU, Mainland China |
| OPE-07 | Short-term outcome of kidney allografts with biopsy-proven pre-existing diabetic nephropathy: the value of Remuzzi score and RPS grade. Jiali WANG, Mainland China |
| OPE-08 | Drug-eluting embolizer transarterial chemoembolization for hepatocellular carcinoma: Efficacy of different particle sizes in downstaging or bridging in living donor liver transplantation Kuan Siong SIM, Taiwan |
| OPE-09 | Validation of original and modified pathological scoring systems for prognostic value in donor kidney core biopsy. Jinghong TAN, Mainland China |
| OPE-10 | Diagnostic value and assessment of treatment efficacy of 18F-FDG PET/CT in pediatric patients with posttransplant lymphoproliferative disorder after liver transplantation Jing-Yi LIU, Mainland China |
| Session: | Outcomes Date: 27 Aug | Time:1420-1600 | Venue: Hall B |
| Chairs : | Jeff WC DAI, Hong Kong, China Ai-Hua YAO, Mainland China |
| OPF-01 | Long-term Outcomes of Liver Transplantation for Methylmalonic Acidemia: New Insights into Health-related Quality of Life Yi-Zhou JIANG, Mainland China |
| OPF-02 | Epidemiology and risk factors of early bacterial infections after pediatric living donor liver transplantation Itsuko Chih-Yi CHEN, Taiwan |
| OPF-03 | Predictive model of EBV-related PTLD after liver transplantation in children Jing-Yi LIU, Mainland China |
| OPF-04 | Relationship between arterioplasty and renal prognosis in renal transplantation Shota INOUE, Japan |
| OPF-05 | SARS-CoV-2 antibody kinetics after vaccination in kidney transplant recipients: Multicenter study Rikako OKI, Japan |
| OPF-06 | Renal outcomes of recipient and donor according to predonation GFR John Neal BASTONA, Philippines |
| OPF-07 | SGLT2 inhibition in kidney transplant recipients: a 6-year experience Maggie K. M. MA, Hong Kong, China |
| OPF-08 | Frailty and lean tissue wasting predict transplant waitlist candidacy and delisting Chun Kau Gordon CHAN, Hong Kong, China |
| OPF-09 | The impact of COVID-19 on heart transplant recipients in an Asian city Ka Lam WONG, Hong Kong, China |
| OPF-10 | Comparison of outcomes of DSAEK(Descemet’s Stripping Automated Endothelial Keratoplasty) and DMEK(Descemet's Membrane Endothelial Keratoplasty) by novice surgeons Gillian SIU, Hong Kong, China |
| OPF-11 | Tectonic deep anterior lamellar keratoplasty to treat corneal perforation and descemetocele from microbial keratitis Hong NGUYEN, Vietnam |
| Session: | Xenotransplantation, Donation and Ethics Date: 27 Aug | Time:1420-1600 | Venue: Theatre 2 |
| Chairs : | Bjiorn NASHAN, Mainland China Dengke PAN, Mainland China |
| OPG-02 | Screening PBMCs for porcine CMV rather than serum is predictive for transplant outcomes after pig to cynomolgus xenogeneic kidney transplantation Eun Sung JEONG, South Korea |
| OPG-03 | Could a decellularization protocol be validated without talking about HLA? Julie MANON, Belgium |
| OPG-04 | Impact of COVID-19 on corneal donation and transplantation in Hong Kong Wing Yan Rachel TSUI, Hong Kong, China |
| OPG-05 | Improving donation through education for health professionals: Belt & Road Organ Donation Capacity Improvement Cooperation Training Project (BROAOD) Jie ZHAO, Mainland China |
| OPG-07 | To achieve effective communication with organ donor family: Key points from the Chinese expert consensus working group Wenshi JIANG, Mainland China |
| OPG-09 | The current situation deceased donor organ transplantation development in Mongolia Batchuluun PANDAAN, Mongolia |
Remark: The above programs are subject to change without prior notice.
